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ARTICLE
Compensatory ion transport buffers daily protein
rhythms to regulate osmotic balance and cellular
physiology
Alessandra Stangherlin 1, Joseph L. Watson 1, David C. S. Wong 1, Silvia Barbiero 1, Aiwei Zeng 1,
Estere Seinkmane 1, Sew Peak Chew 1, Andrew D. Beale 1, Edward A. Hayter 2, Alina Guna3,
Alison J. Inglis4, Marrit Putker1,11, Eline Bartolami5,12, Stefan Matile5, Nicolas Lequeux6, Thomas Pons 6,
Jason Day 7, Gerben van Ooijen 8, Rebecca M. Voorhees4, David A. Bechtold 2, Emmanuel Derivery 1,
Rachel S. Edgar9, Peter Newham 10 & John S. O’Neill 1✉
Between 6–20% of the cellular proteome is under circadian control and tunes mammalian
cell function with daily environmental cycles. For cell viability, and to maintain volume within
narrow limits, the daily variation in osmotic potential exerted by changes in the soluble
proteome must be counterbalanced. The mechanisms and consequences of this osmotic
compensation have not been investigated before. In cultured cells and in tissue we find that
compensation involves electroneutral active transport of Na+, K+, and Cl− through differ-
ential activity of SLC12A family cotransporters. In cardiomyocytes ex vivo and in vivo,
compensatory ion fluxes confer daily variation in electrical activity. Perturbation of soluble
protein abundance has commensurate effects on ion composition and cellular function
across the circadian cycle. Thus, circadian regulation of the proteome impacts ion home-
ostasis with substantial consequences for the physiology of electrically active cells such as
cardiomyocytes.
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The abundance of many proteins exhibits ~24 h rhythms,regulated by cell-autonomous circadian timing mechan-isms that align physiology with the day–night cycle1–6.
Between 6 and 20% of cellular proteins are under circadian
control, and the expression of most oscillating proteins peaks
during translational “rush hours” that typically coincide with the
organism’s habitual active phase1–7. Daily regulation of
mechanistic target-of-rapamycin complexes (mTORC) partitions
phases of increased protein production (increased mTORC
activity) from those of increased catabolism (decreased mTORC
activity)8–11. This temporal organization of protein homeostasis
(proteostasis) permits the most efficient use of bioenergetic
resources, both in vivo and in cultured mammalian cells8–10,12–14.
How cellular protein concentration varies over circadian time in
different intracellular compartments is currently unknown.
In the crowded cytosol, macromolecules (300–550 mg/mL15)
and K+ ions (~145 mM16) are the major determinants of cyto-
solic osmotic potential, balanced by high extracellular con-
centrations of Na+ and Cl− ions. Cells must therefore
accommodate any daily variation in cytosolic protein abundance
without compromising osmotic homeostasis (osmostasis), which
would have deleterious effects on cellular function and
viability17–20. Regulatory volume increase/decrease (RVI/D)
describes the several osmoregulatory mechanisms that act in
concert to protect cell volume against acute changes in extra-
cellular tonicity17,21. However, very little is known about how
cells compensate for physiological changes in intracellular mac-
romolecule content to remain in osmotic equilibrium during the
circadian cycle.
Major components of RVI/D are the electroneutral cotran-
sporters of the SLC12A family: ubiquitously-expressed sympor-
ters that regulate transmembrane ion gradients and cell volume
across a wide variety of tissues22. These chloride cotransporters
couple ion transport with the respective transmembrane Na+ and
K+ gradients that are ultimately established by the universal and
essential Na/K-ATPase antiporter17. The ubiquitous Na-K-Cl
(NKCC1/SLC12A2) cotransporter facilitates electroneutral sec-
ondary active ion influx (import of 1 Na+, 1 K+, with 2 Cl−),
whereas the ubiquitous K-Cl (KCC1/SLC12A4) cotransporter
facilitates electroneutral ion efflux (export of 1 K+ and 1 Cl−)22.
KCC3/SLC12A6 and KCC4/SLC12A7 function similarly to KCC1
and are widely expressed, whereas paralogous KCC2 is neuron-
specific. NKCC2/SLC12A1 and NCC/SLC12A3 expression are
restricted to a few tissues23,24, while CIP/SLC12A9 and CCC9/
SLC12A8 are widely expressed but poorly characterized25.
Changes in the relative activity of NKCC and KCC isoforms
regulate intracellular ion levels, Cl− in particular. During neu-
ronal development, for example, progressively increasing KCC2
activity reduces intracellular Cl− and mediates the transition
between excitatory and inhibitory GABA signaling26,27. Fur-
thermore, differential KCC/NKCC activity is thought to mediate
GABAergic synaptic plasticity of circadian regulation in the
mammalian suprachiasmatic nucleus28,29.
Several SLC12A cotransporters show high amplitude circadian
rhythms at the mRNA level4,30, but their activity is primarily
regulated post-translationally via a coordinated network of
kinases, including the essential serine/threonine kinase oxidative
stress response kinase 1 (OXSR1) and its paralog SPAK17,31. A
large body of evidence supports the differential regulation of
SLC12A cotransporters by OXSR1/SPAK: phosphorylation of
NKCC allows ion import (Na+, K+, and Cl−) whilst phosphor-
ylation of KCC attenuates ion export (K+ and Cl−)31,32. The
activity of OXSR1/SPAK is regulated upstream through phos-
phorylation by lysine deficient protein kinase family members
(WNKs), which are stimulated by molecular crowding and low
cytosolic Cl−31–33. Daily variation in the phosphorylation of
WNK isoforms has been reported in mouse liver12 and
forebrain30, as has the phosphorylation of several members of the
SLC12A family30,34. Importantly, inactivating mutations of genes
encoding SLC12A family members, WNK paralogs, and OSR1/
SPAK underlie a wide range of inherited human diseases,
including pseudohypoaldosteronism type II, Gitelman and Bart-
ter syndromes, highlighting the importance of the WNK-OXSR1/
SPAK-SLC12A pathway for normal physiology31,35–37.
Here, we describe a fundamental and isovolumetric process
whereby electroneutral ion transport buffers intracellular osmotic
potential against daily and acute variations in cytosolic soluble
protein abundance. Consequently, the ionic composition of the
cell is not constant throughout the day, as has been assumed38.
We found that dynamic changes in ion abundance drive oscil-
lations in cellular physiology that impart temporal regulation to
cardiomyocyte cell function and heart rate. More broadly, our
data suggest that the cellular capacity for dynamic ion transport is
important for protein homeostasis.
Results
Cell-autonomous rhythms in soluble protein abundance. Up to
a fifth of the cellular proteome exhibits 24 h cycles in
abundance1–7, due in part to circadian oscillations of mTORC1
activity, ribosome biogenesis, and global protein synthesis
rates10,39,40. We confirmed that mTORC1 activity rhythms occur
cell-autonomously in quiescent adult mouse fibroblasts, main-
tained under constant conditions (37 °C), following synchroni-
zation by daily temperature cycles (12 h:12 h 32 °C:37 °C) (Fig. 1a,
Supplementary Fig. 1a).
mTORC1 activation stimulates translation41, cytoplasmic
targeting of many different macromolecules, and macromolecular
crowding42. We therefore asked whether we could detect
circadian oscillations in the level of soluble cytosolic protein,
since many rhythmically abundant proteins localize to this
compartment. Total protein lysates and cytosolic soluble extracts
(hereafter “soluble protein”) were prepared from fibroblast
cultures over three consecutive days, under constant conditions
as above (Supplementary Fig. 1a), and selective lysis of the plasma
membrane by digitonin was confirmed by mass spectrometry
(Supplementary Fig. 1b, c)43. While total cellular protein showed
no oscillation, we detected clear ~24 h rhythms in the
concentration of soluble protein extracted from cells (Fig. 1b,
Supplementary Fig. 1d). Peaks were observed 4–6 h after the peak
of the clock reporter PER2::LUC (PERIOD 2-firefly LUCIFER-
ASE fusion reporter44), coinciding with both maximal mTORC1
activity (Fig.1a) and increased translation rate in the soluble
fraction (Fig. 1c).
These findings were validated using cellular fractionation by
differential centrifugation, following lysis by NP-40 at biological
times corresponding to the peak and trough of the soluble protein
rhythm (Fig. 1d). While total protein levels did not change, we
observed reciprocal time-of-day variation in protein abundance
between the cytosolic and nuclear/organellar fractions. This is
compatible with a cell-autonomous daily rhythm in the
sequestration of cytosolic proteins to other cellular compartments
or membrane-less organelles, which has been observed in several
model organisms45–47. Whether daily cycles of cytosolic protein
levels are primarily attributable to rhythmic protein synthesis/
degradation or rhythmic protein sequestration/liberation war-
rants further investigation. However, we can exclude pH-
dependent changes in cytosolic protein solubility, since no
variation in cytosolic pH was detected over the cellular circadian
cycle (Supplementary Fig. 2).
Macromolecular crowding describes the concentration-
dependent effect that overall macromolecular abundance has on
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the activities of macromolecules, as well as on the bulk solvent.
Diffusion of macromolecules in the cytosol is sensitive to several
factors, particularly macromolecular crowding i.e., as macro-
molecule concentration increases, the diffusion of macromole-
cules decreases48–50. This can be measured directly from the
diffusion of inert quantum dot nanoparticles (QDs, 20 nm
diameter), both in solution and in cells (Supplementary Fig. 3
a–c). Proteins are the most abundant macromolecule in
mammalian cells51. Therefore, to further validate the observed
rhythm in cytosolic protein concentration, we measured the
diffusion of QDs in the cytosol52, reasoning that changes in
cytosolic protein concentration during the circadian cycle should
inversely impact the diffusion of QDs. In line with prediction, we
observed time-of-day variation in the effective diffusion coeffi-
cient of QDs, with faster diffusion occurring when protein
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Fig. 1 Circadian variation in cytosolic protein content in mouse fibroblasts. a Cell-autonomous circadian mTORC1 activity detected by immunoblots of
phospho-S6 kinase and S6 kinase abundance in fibroblasts sampled every 3 h over 3 days in constant conditions (n= 3) (right). Blot quantification and
parallel PER2::LUC bioluminescent clock reporter (n= 3) (left). b Total and soluble protein quantification of cell lysates sampled ever 4 h (n= 3) and
parallel PER2::LUC bioluminescent clock reporter in fibroblasts (n= 3). Protein abundance values were normalized for the maximal value in each
timeseries. c 35S-met/cys incorporation assay at peak (36 h/60 h) and trough (24 h/48 h) of S6K phosphorylation rhythms (n= 4) and parallel PER2::LUC
activity (n= 3). d Protein quantification of total cell lysates, nuclear/organellar, and cytosolic fractions at peak (36 h/60 h) and trough (24 h/48 h) of
protein rhythms (n= 3). e Effective diffusion rate of QDs in fibroblasts (n= 81, 83, 51, 63, respectively) and representative tracking images. Color key
represents diffusion rate. Scale bar: 1 µm. Mean ± SEM shown throughout. p-values in (b) indicate comparison of damped cosine wave with straight-line fit
(null hypothesis= no rhythm). Significance was calculated using one-way ANOVA and Tukey’s multi comparisons test (MCT) (c), one-way ANOVA and
Sidak’s MCT (d), and Kruskal-Wallis with Dunn’s MCT (e). Cell type used was lung fibroblasts for (a–d) and cardiac fibroblasts for (e).
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Importantly, mTORC inhibition with a low, subsaturating
concentration of the inhibitor torin153 attenuated the peak of
soluble protein rhythms (Supplementary Fig. 4a), and commen-
surately diminished the daily variation in molecular crowding
reported by QD diffusion (Supplementary Fig. 4b). As would be
expected, the effect of torin1 on soluble protein and crowding was
most apparent at biological times when mTORC1 is maximally
active, compared with 12 h later. Overall, these observations
suggest that there are cell-autonomous daily rhythms in cytosolic
soluble protein abundance and molecular crowding. These
rhythms are at least partially dependent on cell-autonomous
circadian regulation of mTORC1 activity, through some combi-
nation of rhythmic protein production and differential associa-
tion of cytosolic proteins with other cellular compartments.
Antiphasic oscillations in soluble protein and intracellular ion
abundance. Most cells are highly permeable to water, and
therefore susceptible to changes in volume upon osmotic chal-
lenge. Tissue fluid homeostasis ensures that cells are rarely subject
to acute perturbations in extracellular osmolarity, but they must
defend cell volume against fluctuations in intracellular
osmolarity6,17. Indeed, within the densely crowded cytosolic
compartment (where [macromolecules] is 300–550 mg/mL15)
small changes in protein concentration elicit large changes in
osmotic potential (Supplementary Fig. 5). Without compensatory
mechanisms, the high amplitude rhythm in soluble protein we
observe would result in potentially deleterious oscillations of cell
volume, as water moves over the plasma membrane to maintain
osmotic equilibrium21. As we have observed previously,
however2, there was no commensurate daily variation in cell
volume (Fig. 2a, Supplementary Fig. 6a), meaning that cells
successfully buffer osmotic potential against gradual changes in
cytosolic protein concentration over circadian timescales.
In light of prior observations9,45,54, we hypothesized that
transmembrane ion flux was responsible for this isovolumetric
compensatory mechanism. We focused on metal ions, the most
abundant osmotically active species in cells (Supplementary
Table 1), and analysed the intracellular ionic composition of
primary fibroblasts across three circadian cycles by inductively
coupled plasma-mass spectrometry (ICP-MS)55. Importantly, we
observed ~24 h ion rhythms for intracellular K+, Na+, and Cl−,
which oscillated in antiphase with soluble protein (Fig. 2b,
Supplementary Table 2): ions are exported when soluble protein
increases and imported when soluble protein decreases. Several
other biologically relevant ions were not similarly rhythmic
(Supplementary Fig. 6b).
To assess whether the ion and cytosolic protein rhythms are
under cell-autonomous circadian control, we analysed cells from
short period tau mutant mice56, which express circadian rhythms
that run faster than wild type. Soluble protein and ion abundance
oscillated in antiphase, as with wild-type cells, but showed
correspondingly shorter period oscillations (~21 h) (Fig. 2c,
Supplementary Fig. 6c). In a parallel investigation, which
compared CRYPTOCHROME-deficient with wild-type
fibroblasts57, we found that the amplitude of soluble protein
rhythms correlated directly with the amplitude of cellular K+
rhythms, which remained in antiphase with each other. These
data suggest that cell-autonomous circadian clock mechanisms
coordinate compensatory ion transport to accommodate daily
variation in cytosolic protein content, without volume change.
Reciprocal regulation of soluble protein and intracellular ion
abundance. In concert with other transport systems, the ubiquitous
and essential Na+/K+-ATPase establishes ~10-fold ion gradients
over the plasma membrane, with high K+ and low Na+/Cl− in the
cytosol (Supplementary Table 1). In response to the acute external
osmotic challenge, the net movement of water rapidly re-establishes
osmotic equilibrium, with resultant volume changes then being
quickly countered by solute transport that returns the cell to its
original volume17,58. This homeostatic mechanism, known as reg-
ulatory volume increase/decrease (RVI/D), is common to all
mammalian cells, and its molecular mechanisms are very well
characterized17,22,59–62. K+ is the most abundant cytosolic osmo-
lyte, and as such K+-transport via SLC12A cotransporters con-
stitutes a major component of RVI/D. All SLC12A family members
transport Cl− as obligate counterions, presumably this is essential
for their function since electrostatic constraints would prevent lar-
gescale net cation efflux or import.
RVI/D solute transport systems act to maintain volume and
osmotic homeostasis against external challenge. Given the
isovolumetric and antiphasic rhythms of ions and soluble protein
we observed, it seemed plausible that RVI/D solute transport
systems also maintain volume and osmotic homeostasis against
internal osmotic challenge, i.e., daily changes in soluble protein
concentration are counterbalanced by reciprocal changes in RVI/
D activity but without preceding volume change. This would
predict that the ability of a cell to accommodate increases in
cytosolic protein should be limited by the capacity to effect
compensatory ion export via RVI/D mechanisms, of which the
SLC12A cotransporters are major components. To test this, we
serum-stimulated non-synchronized cells to elicit an acute
mTORC1-mediated increase in soluble protein concentration.
This soluble protein increase was abolished by NKCC1 knock-
down, as well as by transient inhibition of either NKCC1 or
KCC1-4: SLC12A members that facilitate the influx of Na/K+/2
Cl− and efflux of K+/Cl−, respectively (Supplementary Fig. 7a, b).
This indicates that both KCC and NKCC1 activities are
permissive for acute increases in soluble protein levels stimulated
by serum factors. Indeed, the combined inhibition of both the
NKCC and KCC abolished serum-induced protein increases as
effectively as inhibition of mTORC itself (Fig. 2d).
Because intracellular ion abundance varies across the day, we
predicted that at biological times when ion abundance is already
low, the reduced cellular capacity to buffer osmotic potential
should constrain any further increase in cytosolic protein
concentration. Consistent with this prediction, in synchronized
cells no increase in soluble protein was detected upon serum
stimulation of cells at the minima of ion rhythms (36 and 60 h,
when soluble protein is already high, Fig. 2e). Moreover, serum
stimulation elicited no increase in soluble protein at any
timepoints in cells under mTORC inhibition. These findings
suggest a bidirectional dynamic interplay between the transporter
activity and protein levels: whilst mTORC1-dependent changes in
cytosolic protein abundance stimulate compensatory ion trans-
port, the capacity for ion transport restricts the scope for acute, as
well as daily, increases in protein.
Daily regulation of SLC12A transporter activity. In the context
of RVI/D, the coordinated activity of SLC12A family members is
thought to be regulated via WNK-OXSR1/SPAK1 signaling, sti-
mulated by low Cl− and increased macromolecular
crowding32,63–65 (Fig. 3a). We tested and validated predictions
from the current consensus model with a kinase assay for WNK
autophosphorylation in vitro and with cellular assays for OSXR1
activity (Fig. 3b, c, respectively).
Low Cl− and increased macromolecular crowding occur
coincidentally during the circadian cycle, when mTORC1 activity
is high (Fig. 2c, Supplementary Fig. 8a), leading to the prediction
that OXSR1 signaling and net SLC12A-mediated ion transport
should exhibit circadian regulation. Consistent with this, in
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cultured fibroblasts, the phosphorylation profile of
OXSR1 showed cell-autonomous daily rhythms (Fig. 3d), very
similar to that of phospho-S6K (Fig. 1a). At no point was no
OXSR1 phosphorylation observed, indicating some basal KCC
and NKCC activity throughout the circadian cycle. However,
peak OXSR1 phosphorylation coincided with the nadir of Cl−
rhythms and maximal macromolecular crowding (Supplementary
Fig. 8a). Moreover, several recent phospho-proteomics studies
indicate daily variation in the phosphorylation of WNK1-4
paralogs in several tissues, including cultured fibroblasts57, mouse
liver12 and forebrain30 (Supplementary Fig. 8b-d), as well as
rhythms in the phosphorylation of NKCC and KCC
isoforms30,34, suggesting that similar mechanisms operate in vivo.
Over the circadian cycle, and in light of established RVI/D
mechanisms regulating SLC12A transporter activity, our observa-
tions suggest that mTORC-dependent increases in cytosolic
protein are initially facilitated by electroneutral active K+-Cl−
export via KCC, which simply functions to maintain osmotic
equilibrium over the plasma membrane (Fig. 3a, Supplementary
Fig. 9). As cytosolic Cl− levels fall, they will eventually begin to
limit KCC activity, because Cl− is the essential counterion to K+.




































































































































































Fig. 2 Ion flux buffers changes in cytosolic protein abundance in mouse fibroblasts. a Mean cell volume of fibroblasts across time from three
independent recordings. Average cell volume data were normalized for the average of all values within each replicate. b Abundance of selected ions
(n= 4), soluble protein (n= 3), and PER2::LUC bioluminescence recordings (n= 3) in fibroblasts. Abundance values were normalized for the maximal
value in each timeseries. c Quantification of intracellular Na+ (n= 4) and labile cytosolic protein abundance (n= 3) in WT and tau mutant fibroblasts
under constant conditions over 2 days. d % change in soluble protein upon 4 h treatment with 10% serum ± 50 nM mTOR inhibitor torin1 or 10% serum ±
50 μM DIOA and 100 μM Bumetanide (n= 3). e % fold increase in soluble protein upon 4 h treatment with 10% serum ± 50 nM mTOR inhibitor torin1 at
indicated times (n= 4). Mean ± SEM shown throughout. p values in (b) and (c) indicate comparison of damped cosine wave with straight-line fit (null
hypothesis = no rhythm). Statistical tests were one-way ANOVA and Tukey (d) and two-way ANOVA and Sidak’s MCT (e). Cell type used was lung
fibroblasts for (c) and cardiac fibroblasts for (a, b, d, e).
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acts synergistically with decreased Cl− levels to stimulate WNK
activity58, which will then stimulate increased import of Na+ and
Cl− via NKCC. Cytosolic Na+ is exported by several
mechanisms32,63,64,66, whereas Cl− influx provides counterions
to sustain KCC activity. This allows further increases in cytosolic
protein to be accommodated by additional K+/Cl− export,
facilitated by increased Cl− flux in both directions. This phase is
followed by the circadian decrease in mTORC activity, resulting
in gradual reduction of cytosolic protein. The osmotic equili-
brium over the plasma membrane is now maintained by
increased import of Na+, K+, and Cl− via NKCC and other
transporters, with KCC now being much less active. Thus, the
overall consequence of increased mTORC activity signaling is net
K+ export, with much smaller comparative changes in steady-
state Na+ and Cl− levels, whose cellular levels are ~10-fold lower
than K+. Whereas, later decreases in soluble protein are balanced
by net K+ import.
This model predicts that the selective transient inhibition of
KCC or NKCC at the daily peak (36/60 h) or trough (24/48 h) of
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Fig. 3 Circadian regulation of the WNK/OXSR1/SLC12A pathway activity. a Schematic of the WNK/OXSR1 pathway and regulation of the N(K)CC and
KCC transporters. b In vitro kinase activity assays for purified WNK1 and 3-Phosphoinositide Dependent Protein Kinase 1 (PDPK1) upon increasing
concentrations of NaCl or polyethylene glycol (PEG) (n= 1). WNK1 but not PDPK1 is sensitive to increased macromolecular crowding (mimicked by PEG).
Note that WNK1 is inhibited by high concentrations of Cl−. c Phosphorylation of cellular OXSR1 upon hypotonic treatment and serum, indicating that
decreased intracellular Cl− and increased cytosolic crowding lead to OXSR1 phosphorylation (n= 1). d Representative immunoblots and quantification
showing phospho-OXSR1 and OXSR1 abundance in fibroblasts sampled every 3 h for 3 days in constant conditions (n= 3). The asterisk indicates the
P-OXSR1 band. p value indicates comparison of damped cosine wave with straight-line fit (null hypothesis = no rhythm). e Model prediction and data
showing the difference in cytosolic K+ (digitonin-extracted lysates) between cells treated with DIOA (KCC inhibitor) or bumetanide (NKCC inhibitor)
compared with vehicle-treated cells at the indicated time points. Cells were treated for 15 min before sampling (n= 4). Statistical test used was two-way
ANOVA with Sidak’s MCT. Mean ± SEM shown throughout. Cell type used was lung fibroblasts (c–e).
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intracellular K+. We validated these predictions via 15-minute
acute inhibition, observing changes in K+ abundance that suggest
there are distinct phases of net K+ import and export that render
cells more sensitive to KCC inhibition when soluble protein is
increasing, and more sensitive to NKCC inhibition when soluble
protein is decreasing. Similarly, we also found that sustained
OXSR1/SPAK1 inhibition abolished the daily difference in
soluble protein levels (Supplementary Fig. 3c), consistent with
our model where SLC12A-mediated ion transport is required for
return of soluble protein concentration to basal levels, not their
increase. The model we propose for N(K)CC-mediated compen-
satory ion transport pivots around dynamic daily changes in
WNK-OSXR1/SPAK1 activity and differential KCC vs. NKCC
activity, and is primarily informed by acute inhibition of signaling
and transporter function within a circadian cycle, rather than
across it. The molecular mechanisms of SLC12A regulation are
already well-characterized in the context of RVI/D, following
extracellular osmotic challenge17,20,62,67–69, we simply propose
that RVI/D regulation of NKCC1 vs. KCC extends to encompass
intracellular osmotic challenge over the circadian cycle without
significant volume change.
The SLC12A family includes nine members (including KCC1-
4) whose overlapping and semi-redundant functions are impor-
tant for physiological function and overall viability37,70,71. The
same is true for the four WNK paralogs, as well as OSXR1 with
SPAK131,69. This combination of overall essentiality coupled with
the functional redundancy between components, presents a
barrier to the use of genetic approaches for delineating the
specific contribution of individual transporters and kinases over
the circadian cycle. NKCC1 deletion is tolerated, however,
apparently through upregulation of other (non-SLC12A) trans-
porter activities72. Consistent with previous reports70,72,
NKCC1−/− mice showed obvious growth and developmental
defects (small size, deaf, unsteady gait) and weaned in non-
Mendelian ratios. Fibroblasts derived from adult PER2::LUC
NKCC1−/− mice had significantly reduced cellular Na+ and K+
levels with commensurately increased soluble and total protein
levels (Supplementary Fig. 10a). Whilst NKCC1 deletion clearly
perturbs steady-state osmostasis31,37, rather than its daily
dynamics, this genetic evidence further validates the reciprocal
relationship between cellular ion and macromolecular content,
and indicates that NKCC1−/− cells adapt to the loss of this
transporter through a permanently altered set point for osmotic
homeostasis. Importantly, NKCC1−/− cells showed a similarly
proportional increase in soluble protein following serum
stimulation with respect to wild type, which our model predicts
to be initially KCC-mediated, and demonstrates that NKCC1−/−
cells remain competent to facilitate an increase in soluble protein
levels from an altered baseline (Supplementary Fig. 10b).
Critically, however, NKCC1−/− cells showed blunted mTORC1
and OXSR1 activation following serum-stimulation (Supplemen-
tary Fig. 10c), consistent with feedback from osmostasis to
regulate the means of macromolecular synthesis, and consistent
with previous observations45,72. Interestingly, NKCC1−/− knock-
out cells and mice also exhibited lengthened period of circadian
rhythms in cellular gene expression and mouse locomotor activity
(Supplementary Fig. 11). This is not especially surprising, since
mTORC1 signaling regulates circadian rhythms8, and mTORC1
activation is regulated by the capacity for effecting compensatory
ion efflux, which will be less efficient without NKCC1 to facilitate
Cl− recycling according to our model (Supplementary Fig. 9).
Cell-autonomous rhythms in cardiomyocyte activity and heart
rate. We next considered the physiological consequences of daily
rhythms in intracellular ion content. The concentrations of Na+,
K+, and Cl− across the plasma membrane and their membrane
permeability determine cellular resting potential and the elec-
trophysiological properties of excitable cells38. We therefore
employed primary mouse neonatal cardiomyocytes as a model
system in which to test how cell-autonomous circadian regulation
of ion abundance might impact upon cellular electrical activity.
As with primary fibroblasts, we observed ~24 h cell-autonomous
rhythms in intracellular Na+, K+, and Cl− content (Fig. 4a,
Supplementary Fig. 12a). To assess the relevance of such rhythms
in vivo, we harvested whole heart tissue every 4 h from adult mice
under diurnal conditions and analysed intracellular ion abun-
dance by ICP-MS (Fig. 4b). We observed a significant variation in
the intracellular abundance of Na+ and K+, with ion content
peaking at biological times equivalent to the end of the rest
phase when mTORC activity and soluble protein are normally
low10,11.
Pacemaker cardiomyocytes spontaneously depolarize and fire
action potentials. Spontaneous depolarization is due to a mixed
Na+ and K+ inward current (Funny-like current)73,74, which is
affected by K+ and Na+ gradients across the plasma membrane.
The slope of this slow depolarization phase, known as the
pacemaker potential, determines the frequency of action potential
firing. Our data predict that depolarization should occur more
quickly when intracellular ion concentrations are high, permitting
firing to occur with higher frequency. To test this, we cultured
primary cardiomyocytes on multielectrode arrays, and measured
firing rate over two days, 12 h apart, at biological times
corresponding to the peak and trough of ion rhythms. We
observed a time-of-day variation in firing rate, with more
frequent action potential firing when ion levels are high (Fig. 4c,
Supplementary Fig. 12b). To test the relevance of reciprocal
regulation of protein and ion abundance, we performed the same
experiment upon inhibition of mTORC activity. We reasoned
that the attenuation of protein rhythms should flatten ion
rhythms and associated oscillations in cellular function. Indeed,
torin1 reversibly abolished the time-of-day dependent variation
in cardiomyocyte activity (Fig. 4d). Of note, the effect of torin1 on
action potential firing frequency was most evident at 12 and 36 h,
when mTORC activity and soluble protein are normally high11.
Taken together, these data are consistent with a model whereby
cell-autonomous, time-of-day variation in cardiomyocyte elec-
trical activity is driven, at least in part, by the coupling of cellular
ion content to ~24 h rhythms in cytosolic protein abundance.
In line with this model, we observed time-of-day dependent
variation in heart rate (HR) in Langendorff-perfused hearts from
adult mice. Importantly, the time-of-day tissue-intrinsic varia-
tions in HR were abolished by mTORC1 inhibition, consistent
with our findings in isolated cardiomyocytes (Fig. 4e, Supple-
mentary Fig. 12c). Diurnal variation in HR is known to be
modulated by autonomic nervous system input75,76, but our data
in isolated cardiomyocytes and ex vivo hearts reveal circadian
regulation by cell-autonomous mechanisms intrinsic to the heart.
Concordant with this, time-of-day variation in HR was observed
in vivo under complete autonomic blockade (via intraperitoneal
injection of metoprolol and atropine), indicating significant
modulation of HR by a circadian clock within the heart in vivo
(Fig. 4e, Supplementary Fig. 12d). More specifically, in a parallel
study, we found that time-of-day variations in RR and QT
intervals were maintained under autonomic blockade, implying
local circadian control77. Under these conditions, the daily
variation in HR was also abolished by mTORC1 inhibition
(Fig. 4e, f, Supplementary Fig. 12d). This result suggests that cell-
autonomous mTORC1-dependent changes in cardiomyocyte ion
content contribute to intrinsic HR, allowing the heart to beat
faster around subjective dusk—the biological time when the
greatest cardiac output is required (Supplementary Fig. 12e).
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Discussion
Maintenance of osmotic homeostasis and cell volume is a pre-
requisite for cell viability19,20, explaining the complex osmor-
egulatory system that protects cells from acute osmotic
insults17,31. Very little consideration has been given to the
osmotic challenge cells face over circadian time due to intracel-
lular variation in macromolecular concentration, however, or the
mechanisms that buffer such daily oscillations and enable the
cytosol to remain in osmotic equilibrium with the extracellular
environment. We addressed this aspect of cell physiology in
mouse fibroblasts, where we identified cell-autonomous rhythms
in soluble protein abundance and molecular crowding sustained
by daily rhythms of mTORC activity, in the absence of any
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Fig. 4 Ion fluxes facilitate circadian modulation of cardiomyocyte electrophysiology. a Abundance of selected ions and PER2::LUC reporter activity in
primary cardiomyocytes (n= 4) under constant conditions. Values were normalized to maximal values in each timeseries. p values indicate comparison of
damped cosine wave with straight-line fit (null hypothesis = no rhythm). b Cellular ion content of adult mouse heart tissue under diurnal conditions (n= 3,
normalized to total protein). c Representative field potential traces of cardiomyocytes at peak or trough of ion rhythms and action potential frequency
(representative biological replicate, mean signal from active electrodes is shown, n= 5, 11, 4, and 11, respectively). d Action potential frequency in primary
cardiomyocytes at peak and trough of ion rhythms in the presence of the mTOR inhibitor torin1 (50 nM), and wash off from a representative biological
replicate (mean values from active electrodes are presented, n= 12, 8, 13, and 9 for torin1 and 10, 3, 3, and 5 for wash off). e Heart rate (HR) measured
ex vivo in Langendorff-perfused hearts from control and rapamycin-treated mice collected at ZT0 and ZT12 (n= 6 control ZT0, n= 8 control ZT12, n= 6
mTORC inhibition ZT0, n= 8 mTORC inhibition ZT12). f HR measured in vivo by telemetry in control (n= 6) or rapamycin-treated mice (n= 5) treated
with metoprolol and atropine. Time-of-day variation in heart rate persists under complete autonomic blockade. Mean ± SEM shown throughout. Statistical
tests are one-way ANOVA with Tukey’s MCT (b) and (c), Two-way ANOVA with Dunnett’s MCT (d), one-way ANOVA, and Sidak MCT (e), and mixed-
effect analysis and Sidak MCT (f).
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composition of the cells across time, we detected antiphasic
oscillations in the intracellular abundance of several ions,
including Na+, K+, and Cl−: ions are exported upon increases in
soluble protein and imported upon decreases in soluble protein.
Our data strongly support a model that is entirely consistent with
the current understanding of RVI/D, whereby WNK-OXSR1/
SPAK signaling coordinates circadian regulation of ion influx and
efflux to facilitate the daily rhythms in net K+ transport through
differential regulation of SLC12A transporter activity.
SLC12A members are not the only transporters that facilitate
RVI/D under acute challenge17,78, and so are unlikely to be the
only effectors of compensatory circadian solute transport. Nor is
K+ the only cellular osmolyte of relevance to osmotic compen-
sation, it is merely the most abundant (by an order of magnitude).
Moreover, yeast cells, which lack close homologues of SLC12A
family transporters in the plasma membrane, but do have
OSXR1/SPAK orthologs, show the same antiphasic rhythms of K
+ and soluble protein that we observed in mouse fibroblasts45.
Thus, whilst we do not discount that other transporters, such as
LRRC8 family members78, contribute to circadian ion fluxes, our
observations indicate that SLC12A-mediated electroneutral ion
transport is an important mitigator of the osmotic challenge
presented by daily rhythms in soluble protein abundance; thereby
allowing the cytosolic composition to change each day whilst
defending osmostasis and cell volume. Because the transport of
small osmolytes buffers intracellular osmotic potential against
changes in cytosolic macromolecule concentration, the cellular
capacity for K+-export likely confers daily variation upon the
capacity of cells to respond to exogenous stimuli through changes
in protein expression.
The fundamental rhythmic process we identified has important
implications for the physiology of electrically active cells, such as
cardiomyocytes, which exhibit the same rhythms in cellular ion
content. By performing field potential recordings at biological
times corresponding to the peak and trough of ion rhythms, we
indeed found a time-of-day variation in the action potential firing
rate of isolated cardiomyocytes. Since mTORC inhibition abol-
ished daily firing variation in cardiomyocytes, isolated hearts, and
in vivo, mTORC-dependent daily variation in ion content may be
the major cell-autonomous factor that imparts circadian organi-
zation to cardiac electrical activity. This highlights that soluble
protein concentration can directly impact intracellular ion con-
tent, and thereby modulate cell electrophysiology.
Diurnal variation in heart rate is largely thought to be
regulated by the sympathetic and parasympathetic nervous
systems79. However, data presented here and our recent study77
demonstrate that time-of-day variation in heart rate occurs
even under complete autonomic blockade, revealing some level
of cell-autonomous regulation. Both in vivo and in vitro, the
cellular increase in ion content, which increases cell-intrinsic
electrical activity, coincides with the beginning of the active
phase when basal cardiac output must undergo the greatest
shift. We suggest that cell-autonomous cardiomyocyte clocks
organize the daily timing of mTORC activity and global protein
synthesis/degradation so that the highest cytosolic ion levels
occur in anticipation of the biological time-of-day when the
heart needs to work hardest (Supplementary Fig. 6e), in concert
with central autonomic control. Reduced amplitude of ion
rhythms, or their temporal misalignment with sympathetic
stimulation, will attenuate the intrinsic capacity of cardio-
myocytes to facilitate increased heart rate at this time. For
humans, we propose that dysregulation of cardiac ion or pro-
tein rhythms, during shift work or aging, renders the heart less
competent to satisfy increased output demand in the early
morning, contributing to the increased frequency of adverse
events at this time80–85.
To arrive at this new understanding for the temporal regulation
of cellular physiology, we focused primarily on cultured fibroblast
cells, a most tractable model of the cellular mammalian clock.
However, the same timekeeping mechanisms, rhythms in
mTORC activity, and daily variation in ion transport have been
observed in other cellular contexts, both ex vivo and
in vivo8–11,29,86. Based on our similar recent findings in human,
algal, and fungal cells9,45, we predict that rhythms in ion trans-
port will be observed in any eukaryotic cell with oscillations in
mTORC activity, circadian, or otherwise. Future work is needed
to explore the many potential cellular and physiological con-
sequences of ion transport rhythms for other aspects of cellular
function, as well as identifying which proteins change their
cytosolic localization over the course the circadian cycle and how
this impacts their activity.
Finally, our data suggest that reciprocal regulation of ion and
protein abundance is a ubiquitous cellular mechanism for
osmotic homeostasis, which we expect will be of broad relevance
to understanding human physiology and disease. For example,
since the capacity to buffer cytosolic osmotic potential is reduced
when cytosolic ion levels are low, it is tempting to speculate that
this may render neural cells more susceptible to protein mis-
folding and aggregation toward the end of the daily activity cycle,
when most mammals normally seek to rest and sleep.
Methods
Fibroblast isolation, culture, and entrainment. Lung fibroblasts were isolated
from adult lung tissues87 of WT (C57BL6), WT PER2::LUC, and TAU
PER2::LUC56 mice and immortalized by serial passage. Fibroblasts were cultured in
DMEM high glucose (Thermo Fisher Scientific, 31966-021) supplemented with
10% serum (GE Healthcare, Hyclone™III SH30109.03) and Penicillin/Streptomycin
(Pen/Strep) (Thermo Fisher), at 5% CO2 and 37 °C.
Primary cardiac fibroblasts and cardiomyocytes were isolated from the hearts of
P2-P3 neonatal mice using a commercially available dissociation kit following
manufacturer’s instructions (Miltenyi Biotec, 130-098-373). In brief, heart tissue
was removed and stored on ice-cold dissociation buffer (106 mM NaCl, 20 mM
HEPES, 0.8 mM NaH2PO4, 5.3 mM KCl, 0.4 mM MgS04, 5 mM glucose). Blood
vessels and connective tissue were removed and the remaining cardiac tissue was
dissected into small sections and digested. After enzymatic dissociation and
enzyme inactivation, the digested tissue was filtered through a 70 μm filter (Greiner
bio-one, 542070) and placed in 10 cm dishes for 2 h. The supernatant containing
cardiomyocytes was collected and seeded in 96 well plates or microelectrode array
chips at 1000 cells/mL density using “first day medium” (DMEM high glucose
supplemented with 17% M199 (Thermo Fisher, 31150-055), 10% horse serum, 5%
newborn calf serum, Glutamax, Pen/Strep, and Mycozap (Lonza)). On the day after
the isolation, the medium was replaced with “second day medium” (DMEM high
glucose supplemented with 17% M199, 5% horse serum, 0.5% newborn calf serum,
Glutamax, Pen/Strep, and Mycozap). The preplating step allows for positive
selection of primary cardiac fibroblasts that were then either kept primary (5% O2
incubator) or immortalized by serial passage.
The type of fibroblast used (either lung or cardiac) is indicated in the figure
legends. Based on previous experiments we believe that there is no difference in
circadian phenotype between the fibroblasts of different tissue origin.
Bioluminescence recordings. Cells were seeded and grown to confluence. Cells
were then synchronized using temperature cycles of 12 h at 32 °C followed by
12 h at 37 °C for a minimum of 3 days. Bioluminescence was recorded using a
culture medium supplemented with 1 mM luciferin (and drugs where indicated)
at 5% CO2. Cells were imaged using ALLIGATORs (Cairn Research) as
described previously88, where bioluminescence was acquired for 29 min at 30-
min intervals, at constant 37 °C. Mean pixel intensity from each region of
interest was extracted using Fiji89. For period calculation, bioluminescence traces
were detrended by 24 h moving average and fit using GraphPad Prism with a
damped cosine wave (where y is the signal, x the corresponding time, the
amplitude is the height of the peak of the waveform above the trend line, k is the
decay constant (such that 1/k is the half-life), phase is the shift relative to a cos
wave and the period is the time taken for a complete cycle to occur). Cellular
bioluminescence measurements in Supplementary Fig. 2 employed a MOPS-
buffering system in place of bicarbonate to allow pH to be adjusted (DMEM
powder (Sigma D5030), 0.35 mg/mL sodium bicarbonate, 5 mg/mL glucose,
0.02 M MOPS, 100 U/mL penicillin, 100 μg/mL streptomycin), as described
previously88. Supplementary Fig. 2c–f employed a Tecan Spark 10 M, whereas
Supplementary Fig. 2g employed a Lumicycle (Actimetrics).
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Protein extraction and quantification. For cytosolic soluble protein extraction,
cells (equal number per replicate and per condition) were washed twice with
phosphate-buffered saline (PBS) and incubated with a digitonin-based lysis buffer
(50 mM tris pH 7.4, 0.01% digitonin, 5 mM EDTA, 150 mM NaCl, protease, and
phosphatase inhibitors (Roche, 4906845001 and 04693159001)) on ice for 15 mins.
Only supernatant was collected (without scraping). For total protein determination,
cells were washed twice with PBS and incubated with RIPA buffer (150 mM NaCl,
1% NP-40, 0.5% Na deoxycholate, 0.1% SDS, 50 mM Tris pH7.4, 5 mM EDTA,
protease, and phosphatase inhibitors) on ice for 15 min. After scraping, lysates were
collected and sonicated using a Bioruptor sonicator (Diagenode) (30 s ON, 30 s
OFF). Protein quantification was performed using intrinsic tryptophan
fluorescence90 or BCA assay (Pierce, 23227). Reported in the figures are protein
concentration values normalized as indicated in the axes or in the figure legend.
Subcellular fractionation. Wild-type PER2::LUC lung fibroblasts were seeded in
100 mm dishes (300,000 cells per dish) and grown until confluent in temperature
cycles (12 h 37 °C–12 h 32 °C) for 7 days. Twenty-four hours before the experi-
ment, cells received a last medium change and were moved into constant condi-
tions. Cytosolic, organelle, and nuclear fractions were harvested every 12 h for
2 days using the Nuclei EZ Prep nuclei isolation kit (Sigma NUC-101) according to
manufacturer’s instructions. Briefly, cells were washed with ice-cold PBS, lysed
with Nuclei lysis buffer, scraped, and centrifuged at 500 g at 4 °C for 5 min. Nuclei
pellets were flash frozen. Supernatants were further clarified at 21,000 g at 4 °C for
30 min to get cytosolic fractions, pellets were saved as the organelle fraction, and
both fractions were flash frozen. Once thawed, nuclei and organelle pellets were
resuspended in 200 μL RIPA buffer (150 mM NaCl, 5 mM EDTA pH 8.0, 50 mM
Tris pH 8.0, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, protease, and
phosphatase inhibitors), sonicated 4 times at high power for 30 s at 4 °C to shear
genomic DNA, and centrifuged at 21,000 g for 15 min at 4 °C. Protein con-
centration was measured using BCA assay (Pierce).
Quantification of cholesterol in cell fractions. Wild-type PER2::LUC lung
fibroblasts were seeded in 100 mm dishes and grown until confluent in temperature
cycles (12 h 37 °C–12 h 32 °C) for 7 days. Twenty-four hours before the experi-
ment, cells received a last medium change and were moved into constant condi-
tions. Cells were fractionated into nuclear, mitochondrial, membrane, and cytosolic
fractions every 12 h for 2 days based on a modified previously described protocol91.
At each timepoint, cells were washed with ice-cold PBS, scraped into 1.5 mL tubes,
and lysed with 500 μL fractionation buffer (20 mM HEPES pH 7.4, 10 mM KCl,
2 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, protease, and phosphatase
inhibitors) for 15 min on ice. Cells were lysed by syringe extrusion (10 times
through a 27-gauge needle) and flash frozen. After thawing, the lysate was cen-
trifuged at 720× g for 5 min at 4 °C and the supernatant was transferred to a fresh
tube. The pellet (nuclear fraction) was resuspended in 500 μL RIPA buffer and
passed through a 25-gauge needle. The supernatant was further centrifuged at
10,000× g for 5 min at 4 °C and the supernatant was transferred to 0.5 mL ultra-
centrifuge tubes (Beckman Coulter). The pellet (mitochondrial fraction) was
resuspended in 200 μL RIPA buffer and passed through a 25-gauge needle. The
supernatant was ultracentrifuged at 100,000× g for 1 h at 4 °C in a TLA120.1 rotor
(Beckman Coulter). The supernatant (cytoplasmic fraction) was removed and the
pellet (membrane fraction) was resuspended in 200 μL RIPA buffer and passed
through a 25-gauge needle. In addition, at each timepoint a parallel dish of cells
representing whole cell lysate was lysed in 500 μL RIPA buffer and flash frozen.
Each fraction and the whole cell lysate was sonicated 4 times on higher power for
30 s and centrifuged at 21,000× g for 15 min at 4 °C.
Cholesterol content in each sample was quantified using the Amplex Red
Cholesterol Assay (Invitrogen, A12216) according to manufacturer’s instructions.
Briefly, a standard curve was prepared using the provided cholesterol reference
standards. Twenty-five microliter of each standard and sample was diluted 2x in 1x
Reaction Buffer, added in triplicate to 96 well plates and 50 μL of Amplex Red
Reagent working solution was added (containing 300 μM Amplex Red Reagent,
2 units/mL horseradish peroxidase, 2 units/mL cholesterol oxidase, and 0.2 units/
mL cholesterol esterase). The plates were incubated at 37 °C for 30 min and a Tecan
Spark plate reader was used to measure absorption at 550 nm. The cholesterol
content of the cytoplasmic fraction was below the detection limit.
NKCC1 knockdown. Lung fibroblasts were seeded in 12 well plates and transfected
with either 5 μM of ON-TARGETplus Mouse Slc12a2 siRNA (L-044448-01-0005,
Horixon Discovery) or ON-TARGETplus Nontargeting Control Pool (D-001810-
10-05, Horizon Discovery) using DharmaFECT 1 Transfection Reagent 1 (T-2001-
02, Horizon Discovery) following manufacturer’s instructions. After 72 h, cells
were moved to serum-free DMEM (Thermo Fisher Scientific, 31966-021) for 24 h
and then stimulated with DMEM supplemented with 10% Hyclone III for 4 h. For
knockdown validation total cell lysates were extracted with RIPA buffer, whereas
soluble protein extracts were extracted using a digitonin-based lysis buffer (as
described above).
Western blotting. Equal amounts of total cell extracts were run under denaturing
conditions using NuPAGE Novex 4–12% Bis-Tris gradient gels (Life Technologies).
Proteins were transferred onto nitrocellulose membranes using the iBlot system
(Life Technologies), with a standard (P0, 8 min) protocol. Nitrocellulose was
blocked for 60 min in 5% w/w non-fat dried milk (Marvel) in Tris buffered saline/
0.05% Tween-20 (TBST). Primary antibodies used were: Anti-OXSR1 (Abcam,
ab224248), 1/1000; anti- Phospho-OXSR1 (Abcam, ab138655), 1/1000; anti-S6K
(Cell signaling, 2708), 1/2000; anti-P-S6K (Cell signaling, 9205), 1/1000; anti-
NKCC1 (Cell Signaling, 14581), 1/500; anti-GAPDH (Sigma, G9545), 1/2000;
HRP-conjugated secondary antibody was antirabbit (Sigma-Aldrich, A6154), 1/
5000. Chemiluminescence detection was performed using Immobilon reagent
(Millipore) and the Gel-Doc™ XR+ system (Bio-Rad). Quantification was per-
formed using the ImageJ gel quantification plugin or Image Lab software (Biorad).
To better identify phopho-OXSR1 band, one of the replicate samples was treated
with Calf intestinal alkaline phosphatase (Promega, M182A) for 60 min at 37 °C.
Mass spectrometry and gene ontology analysis
Sample preparation. Unsynchronized cells were washed twice in ice-cold PBS and
then lysed at room temperature with a digitonin-based lysis buffer (50 mM tris pH
7.4, 0.01% digitonin, 5 mM EDTA, 150 mM NaCl, protease, and phosphatase
inhibitors (Roche, 4906845001 and 04693159001)) on ice for 15 min. The super-
natant was collected (without scraping) and processed for mass spectrometry
analysis.
Enzymatic digestion. Samples were reduced with 5 mM DTT at 56 °C for 30 min
and then alkylated with 10 mM iodoacetamide in the dark at room temperature for
30 min. Digestion was performed using mass spectrometry grade Lys-C (Promega)
at a protein:Lys-C ratio of 100:1 (w/w) for 4 h at 37 °C followed by trypsin
(Promega) digestion at a ratio of 50:1 (w/w) overnight. Digestion was quenched
by the addition of formic acid (FA) to a final concentration of 0.5%. Any pre-
cipitates were removed by centrifugation at 18,500 g for 7 min. The supernatants
were desalted using homemade C18 stage tips containing 3 M Empore
extraction disks (Sigma-Aldrich) and 2.5 mg of Poros R3 resin (Applied Biosys-
tems). Bound peptides were eluted with 30–80% acetonitrile (MeCN) in 0.5%
FA and lyophilized.
Tandem mass tag (TMT) labeling. Dried peptide mixtures from each condition
were resuspended in 60 μl of 7% MeCN and 1M triethyl ammonium bicarbonate
was added to a final concentration of 200 mM. 0.8 mg of TMT10plex reagents
(Thermo Fisher Scientific) was re-constituted in 41 μl anhydrous MeCN. 30 μl
of TMT reagent was added to each peptide mixture and incubated for 1 h
at RT. The labeling reactions were terminated by incubation with 7.5 μl of 5%
hydroxylamine for 30 min. The labeled samples were pooled into one single
sample and speed Vac to remove acetonitrile. Labeled sample was desalted
and then fractionated with homemade C18 stage tip using 10 mM ammonium
bicarbonate and acetonitrile gradients. Eluted fractions were combined
into four fractions, acidified, partially dried down in speed vac and ready for
LC-MSMS.
LC MS/MS. The fractionated peptides were analysed by LC-MS/MS using a fully
automated Ultimate 3000 RSLC nano System (Thermo Fisher Scientific) fitted with
a 100 μm× 2 cm PepMap100 C18 nano trap column and a 75 μm× 25 cm,
nanoEase C18 T3 column (Waters). Samples were separated using a binary gra-
dient consisting of buffer A (2% MeCN, 0.1% formic acid) and buffer B (80%
MeCN, 0.1% formic acid), and eluted at 300 nL/min with an acetonitrile gradient.
The outlet of the nano column was directly interfaced via a nanospray ion source to
a Q Exactive Plus mass spectrometer (Thermo Scientific). The mass spectrometer
was operated in standard data-dependent mode, performing a MS full-scan in the
m/z range of 380–1600, with a resolution of 70,000. This was followed by MS2
acquisitions of the 15 most intense ions with a resolution of 35,000 and NCE of
33%. MS target values of 3e6 and MS2 target values of 1e5 were used. The isolation
window of precursor ion was set at 0.7 Da and sequenced peptides were excluded
for 40 s.
Spectral processing and peptide and protein identification. The acquired raw files
from LC-MS/MS were processed using MaxQuant (Cox and Mann) with the
integrated Andromeda search engine (v.1.6.6.0). MS/MS spectra were quantified
with reporter ion MS2 from TMT 10plex experiments and searched against Mus
musculus, UniProt Fasta database (March19). Carbamidomethylation of cysteines
was set as fixed modification, while methionine oxidation, N-terminal acetylation
and were set as variable modifications. Protein quantification requirements were set
at one unique and razor peptide. In the identification tap, second peptides and
match between runs were not selected. Other parameters in MaxQuant were set to
default values.
Gene ontology enrichment analysis. Gene ontology enrichment analysis was per-
formed using PANTHER 14.1 (Protein ANalysis THrough Evolutionary Rela-
tionships) Classification System92. The analysis performed was a statistical
enrichment test, using the Mann-Whitney U test and Benjamini-Hochberg cor-
rection for multiple comparisons.
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35S incorporation assays. PER2::LUC lung fibroblasts were differentially entrained
for a week with external temperature cycles in serum-free DMEM. At the end of
the last cycle, cells were moved into constant conditions. A parallel plate was used
for bioluminescence recording of the clock reporter (phase marker). At the indi-
cated times, the cells were pulsed with 0.1 mCi/ml 35S-L-methionine/35S-L-cysteine
mix (EasyTag™ EXPRESS35S Protein Labeling Mix, Perkin Elmer) in serum-free,
Cysteine/Methionine-free DMEM for 15 min at 37 °C. Afterwards, cells were
washed with ice-cold PBS and lysed in digitonin-based buffer (with protease
inhibitor tablet, added freshly) on ice. Equal amounts of lysates were run on 4–12%
Bis-Tris SDS-PAGE using MES buffer. Gels were then dried at 80 °C and exposed
overnight to a phosphorimager screen. Images were acquired with Typhoon
FLA700 gel scanner, and quantified using Fiji.
Cell volume measurements. WT cardiac fibroblasts were nucleofected with
pCDNA3.1 tdTomato (Neon Transfection kit, Invitrogen, MPIK10025), diluted 1
in 2 with control cells (cell nucleofected with no DNA), and seeded at high density
in μslides (IBIDI, 80826). Cells were grown to confluence and entrained with
temperature cycles. Twenty-four hours before the start of the recording medium
was changed to “Air medium” supplemented with 1% Hyclone III, and plates
sealed. Z-stacks were acquired every hour for 2.5–3 days using a Leica SP8 confocal
microscope. Imaris software (Oxford Instruments) was used for 3D reconstruction,
tracking and determination of cell volume. Cell volume values were then nor-
malized to the mean intensity of tdTomato across time (cell volume/mean inten-
sity). For each dataset, comparison of fit was performed with GraphPad Prism.
Data were fitted with either a straight line or a circadian damped cosine wave.
When a circadian damped cosine wave equation was preferred, only those cells
with a period between 20 and 28 h were considered rhythmic.
Measurement of the effective diffusion rate of Quantum dots
Streptavidin–Quantum Dot synthesis. CdSe/CdS/ZnS core/shell Quantum Dots
(QDs) were synthesized using a high-temperature reaction of metal carboxylates
and sulfur and selenium precursors in octadecene as described previously93. They
were transferred into water by ligand exchange with a block copolymer ligand
composed of a first block of imidazole acting as anchors onto the QD surface and a
second polymer block of sulfobetaine and azido-functionalized monomers93,94.
This second block provides efficient antifouling properties from the sulfobetaine
and is amenable to click chemistry mediated bioconjugation. The resulting QDs
were purified using ultracentrifugation on sucrose gradients and ultrafiltration and
resuspended in HBS buffer (10 mM HEPES, 150 mM NaCl pH 7.5)94. For strep-
tavidin-conjugation, 10 nmol streptavidin were functionalized with dibenzylcy-
clooctyne (DBCO) using a 3:1 ratio of DBCO-NHS:streptavidin in borate buffer
(0.1 M pH 8.0). The proteins were purified from unreacted DBCO-NHS using
ultrafiltration (Vivaspin, 10 kDa cutoff, 2 rounds of 10 min, 13000 g), resuspended
in HBS and mixed with 1 nmol QDs for 24 h at 4 °C. Bioconjugated QDs were
finally purified from unreacted proteins by ultracentrifugation in HBS (2 rounds of
25 min, 120000 g). Before delivery into cells, Streptavidin-QDs were incubated with
a 15-fold molar excess of biotinylated Cell Penetrating Poly(disulfide)s (CPDs)95
overnight at 4 °C in (0.01M HEPES, 150 mM KCl, pH 7). On the day of the
experiments, QD-CPDs conjugates were diluted to a final 1 nM concentration in
growth medium and added onto cells (see below). For the experiment in Supple-
mentary Fig. 2b commercial streptavidin-conjugated QDs (Thermo - Q10101MP)
were used. The different size and coating of these QDs might account for the
different effect size between experiments in Fig.1e and Supplementary Fig. 2b96.
Time-course experiment. WT fibroblasts were seeded in 35 mm dishes (WPI,
FD3510-10), grown to confluence and differentially entrained with temperature
cycles. QD motion was imaged at predicted trough and peak of protein oscillations,
i.e. 24, 36, 48, and 60 h after medium change (DMEM 1% Hyclone III, supple-
mented with 10 mM HEPES to avoid any change in pH during imaging). Briefly,
cells were incubated with 1 nM QD-CPD conjugates for 1 h, washed twice with PBS
and imaged at 37 °C, atmospheric conditions. To prevent any perturbations by
media change, all treatments were performed at 37 °C using the conditioned
medium from the same dishes. For each time-point, we acquired several time-lapse
recordings from 2 to 3 independent replicate dishes (between 22 and 43 movies per
timepoint per replicate), and replicates were subsequently pooled for analysis.
In vitro measurements. For in vitro measurements of quantum dot diffusion,
streptavidin-coated quantum dots (Thermo, Q10101MP) were added at a final
concentration of 200 pM to solutions of 35kD polyethylene glycol or BSA dissolved
at different concentrations in 20 mM Tris pH 7.6 (or as labeled) + 150 mM KCl.
Quantum dots were then imaged in imaging dishes (WPI, FD3510) coated for 1 h
with 0.1 mg/ml PLL-g-PEG (SuSoS, PLL(20)-g[3.5]- PEG(2), dissolved in 10 mM
Hepes pH 7.6). Imaging was performed at 25 °C using the same imaging conditions
as imaging of quantum dot diffusion in cells.
Imaging and image processing. Imaging was performed by spinning disk confocal
microscopy using a custom-built setup based on a Nikon Ti stand equipped with a
perfect focus system, a PLAN NA 1.45 100X objective and a spinning disk head
(Yokogawa CSUX1). QDs were excited by a 488 nm laser (Coherent OBIS mounted
in a Cairn laser launch) and imaged using a Chroma 595/50 emitter filter. Images
were recorded with a Photometrics Prime 95B back-illuminated sCMOS camera
operating in high gain mode (12 bits dynamic range), gain 1 and pseudo global
shutter mode (synchronized with the spinning disk wheel). Each acquisition
consisted of 1000 frames acquired at 62.5 Hz (10 ms exposure, 6 ms readout). The
system was operated by Metamorph.
Estimation of the effective diffusion coefficient of QDs was performed in Fiji89
and MATLAB 2017b (Mathworks) using custom codes available on request. In
brief, for each field of view, QD position was precisely determined by 2D Gaussian
fitting using the plugin Thunderstorm97. Average localization precision across the
entire dataset based on photon count was 14 ± 0.0004 nm (mean ± sem n= 214,
368, 144 QDs). QD trajectories were then tracked using the MATLAB adaptation
by Daniel Blair and Eric Dufresne of the IDL particle tracking code originally
developed by David Grier, John Crocker, and Eric Weeks in MATLAB 2017b
(http://site.physics.georgetown.edu/matlab/index.html).
For each track, the Mean Square Displacement (MSD) of segments of increasing
duration (delay time (t) was then computed (MSDðtÞ ¼ ðΔxÞ2 þ ðΔyÞ2) using the
MATLAB class MSD Analyzer98. MSD curves were then fitted to a subdiffusion
model captured by the function MSDðtÞ ¼ 4Dtα99 with D the effective diffusion
rate. We then filtered the MSD curves to retain only those with a good fit (R² > 0.9)
and with α > 0.5 as we found this was the most accurate way to exclude immobile
particles. Indeed, as shown previously95, QDs delivered by our CPD technology
exhibit both immobile and diffusive motion in cells, and immobile QDs have to be
filtered out as they would artificially lower the estimated diffusion coefficient. We
then accurately estimated the effective diffusion of these filtered tracks by fitting the
first 50 points of their MSD curve by the function MSD(t)= 4Dt. The median of
the effective diffusion rate D was then averaged across all the filtered tracks to give
an estimate of the effective diffusion rate for a given field of view (average number
of filtered tracks per field of view was always >1000). The effective diffusion rates
per field of view were then average for each timepoint of the circadian time-course.
Inductively coupled plasma-mass spectrometry (ICP-MS) analysis—mammalian
cells. For time-course experiments, cells were seeded at high density and grown to
confluence. Cells were entrained for three days with temperature cycles (12 h at
32 °C, 12 h at 37 °C). At the transition to the cold phase of the last cycle, medium
was replaced with fresh medium and cells were moved into constant conditions
(37 °C). Samples were extracted every 3 h for 3 consecutive days, beginning 24 h
after the medium change. Cells were washed once with ice-cold “iso-osmotic buffer
1” (300 mM sucrose, 10 mM Tris base, 1 mM EDTA, pH 7.4 adjusted with phos-
phoric acid (Sigma, 79614, 330–340 mOsm) and once with ice-cold “iso-osmotic
buffer 2” (300 mM sucrose, 10 mM Tris base, 1 mM EDTA, pH 7.4 adjusted with
acetic acid Sigma, 45727, 330–340 mOsm). Cells were then lysed with high purity
65% nitric acid (HNO3, Merk Millipore, 100441) supplemented with 0.1 mg/L (100
ppb) cerium (Romil, E3CE#) as a procedural internal standard. Samples were
diluted in high purity water to a final concentration of 5% HNO3, then run using a
Perkin Elmer Nexion 350D ICP-MS. Data were collected and analysed using
Syngistix version 1.1. Ion concentrations were normalized for a scaling factor based
on cerium abundance and analysed using GraphPad Prism. Outliers were identified
and removed using the ROUT (Q= 0.1%, high stringency) or the Grubbs’ (alpha =
0.2) method in GraphPad Prism. In order to determine circadian rhythmicity, data
were fit by comparing a straight line with a damped cosine wave equation with the
simpler model chosen unless the latter was preferred with p < 0.05.
ICP-MS analysis – heart tissue. Male C57BL/6 J mice kept under 12 h/12 h-light/
dark (L/D) cycles were sacrificed every 4 h, at the indicated zeitgeber times (ZT).
Mice were euthanized by cervical dislocation, confirmed by exsanguination. Heart
tissues were removed and stored on ice in “iso-osmotic buffer 1” (see above).
Tissues were diced into 3 mm slices, washed extensively with ice-cold iso-osomotic
buffer 1 then 2, and gently digested with an NP40-based buffer on a tube rotator
(50 mM tris pH 7.5, 1% NP40, 5 mM EDTA, 50 mM choline bitartrate). Samples
were spun down (21.000 g x 10 min) and the supernatant quantified using BCA
(for protein quantification) and analysed by ICP-MS (for ionic composition). For
each sample, ion abundance was normalized to protein abundance.
Kinase assay. Full-length human WNK1 (residues 1-2382;) was expressed with a
C-terminal MYC-DDK (1xFLAG) tag from a pCMV6-Entry backbone (Origene,
USA, RC218208) in Expi 293 F suspension cells (Thermo Fisher Scientific,
A14527)100. Cells were grown at 37˚C, 8% CO2 and shaking in 1 L roller bottles
with vented caps. A culture of 300 mL of cells at 2×106 cells/mL was transfected
with a mix consisting of 10 mL Expi 293 expression medium, 900 μL 1mg/mL PEI
MAX 40k (Polysciences, 24765-1) and 300 μg DNA, preincubated at room tem-
perature for 15 min. Cells were harvested 36 hours later and spun down at 1000 g
for 5 min. Cell pellets were washed once in PBS and flash frozen. Pellets were
thawed and resuspended in 20 mL lysis buffer A (50 mM Hepes pH 7.5, 125 mM
KOAc, 5 mM MgAc2, 0.5% Triton X-100, 1 mM DTT, 1X PhosSTOP (Sigma-
Aldrich, 4906845001), 1X complete EDTA-free protease inhibitor cocktail (Roche,
11873580001)), and the resulting lysate was centrifuged at 916 g for 30 min in a SS-
34 rotor. The supernatant was mixed with 100 μL anti-FLAG M2 affinity resin
(Millipore-Sigma, USA) and incubated at 4˚C for 90 min. The beads were then
washed with 9 mL of lysis buffer, 12 mL of wash buffer 1 (50 mM Hepes pH 7.5,
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400 mM KOAc, 5 mM MgAc2, 0.1% Triton X-100, 1 mM DTT, 1X complete
EDTA-free protease inhibitor cocktail), and finally 6 mL of wash buffer 2 (50 mM
Hepes pH 7.5, 100 mM KOAc, 5 mM MgAc2, 1 mM DTT, 10% glycerol). WNK1
was then eluted from the resin in 200 μL wash buffer 2 containing 0.25 mg/mL 3X
FLAG peptide.
Recombinant WNK1 kinase domain (residues 1-487) was expressed with a
N-terminal His14-bdSUMO tag in E. coli Rosetta 2 cells (Novagen, 71397).
Expression was induced with addition of 0.2 mM IPTG and cells were grown for
8 hours before harvesting. Cell pellets were resuspended via sonication in lysis
buffer B (50 mM Tris pH 7.5, 300 mM NaCl, 20 mM imidazole, 5 mM DTT, 1 mM
PMSF, 10% glycerol), and the lysate was then centrifuged for 45 min at 1034 g in a
SS-34 rotor. The resulting supernatant was mixed with Ni2+ affinity agarose resin
(Qiagen, 30210) and incubated at 4˚C for 60 min. The resin was washed with two
column volumes (CV) of wash buffer 3 (50 mM Tris pH 7.5, 300 mM NaCl, 20 mM
imidazole) and then with one CV of wash buffer 4 (50 mM Hepes pH 7.5, 300 mM
KOAc, 2 mM MgAc2, 10% glycerol, 5 mM DTT). The recombinant WNK1 kinase
domain was eluted via addition of 50 nM bdSENDP1 protease (Frey et al., 2014;
Addgene ID 104962) in wash buffer 4.
Recombinant PDPK1 was ordered in a purified form (abcam, ab60834). Kinase
assays were performed with 50 ng protein in assay buffer (50 mM Hepes pH 7.5,
100 mM KOAc, 2 mM MgAc2, 0.1 mM ATP, 0.2 mCi/mL γ-32P-ATP, 1X Phos-
STOP) with the indicated concentrations of either NaCl or PEG 20,000 (Sigma,
81300-1KG). Reactions were incubated at 32˚C for 30 min and then quenched with
sample buffer and boiled. Samples were then diluted sevenbfold prior to electro-
phoresis due to the high concentrations of PEG. Incorporation of γ-32P was ana-
lyzed by exposing the gel to a Phosphor screen for 24–72 h. Uncropped blots are
presented in Supplementary Fig. 14.
Microelectrode array (MEA) recordings. Immediately after isolation, 1 × 105 cardio-
myocytes were seeded in a small drop on the center of the MEA chip (Multi Channel
Systems, 60MEA200/30iR-Ti-gr) coated with 10 μg/mL fibronectin (Sigma, F1141).
After 5 h, fresh medium was added. After 8 days in culture, with medium change
performed every day, a last medium change was performed and cells kept in constant
conditions. Field potential from each MEA was then recorded at predicted peaks and
troughs of ion rhythms before returning cells to the incubator between time-points.
Cells were maintained at 37 °C during transfer to and from the incubator. Recording
was done in culturing medium supplemented with 10mM HEPES using the MEA
recording device (MEA2100-2×60-System, Multi Channel Systems). All recordings
were performed at atmospheric conditions with stage and custom-built heated lid
held at 37 °C. MEAs were allowed to equilibrate for 200 s and local field potentials
from all electrodes were recorded at 10 kHz for 10min. Data were recorded and
analysed using the Multi-Channel experimenter and Multi-Channel DataManager
software. Data from individual MEAs (several replicates per experiment) are shown in
the main figures and in supplementary figures.
Langendorff heart electrophysiology. Animals were culled and hearts excised
between ZT0-1 or ZT11-12. Excess tissue was removed under dissection micro-
scope in ice-cold Krebs-Henseleit Buffer (KHB) solution (118 mM NaCl, 11 mM
Glucose, 1.8 mM CaCl2, 4.7 mM KCl, 25 mM NaHCO3, 1.2 mM MgSO4, 1.2 mM
KH2PO4). Hearts were cannulated through the aorta and held in place using fine
thread tied around the aortic vessel. The cannula was then attached to a jacketed
glass coil filled with oxygenated KHB and heart perfused at 37 °C at 4 ml/min. This
whole process took ~3–4 min. Monophasic action potentials were recorded using
custom-made silver chloride electrodes from the left atrial appendage. Any hearts
that did not stabilize within the first 10 min of recording were excluded from
further study. Signals were amplified and digitized using a Powerlab system (4/35)
and analysed in LabChart (v8; ADinstruments, UK). After brief electrical stimu-
lation of the right atrial appendage (600 Hz for 15 s), average heart rate was cal-
culated over 30 seconds of stable recording. Mice in the treated group were given
rapamycin (dissolved in drinking water) for 2 weeks befre culling.
ECG telemetry implantation and analysis. Mice were implanted with telemetry
devices (ETA-F20; Data Sciences International, USA) for electrocardiographic
recording. Mice were anaesthetized with isoflurane, following which the telemetry
remote was inserted into the abdominal cavity. Biopotential leads were secured
~1 cm right of midline at upper chest level (negative) and ~1 cm to the left of
midline at the xiphoid plexus (positive). Mice were allowed a recovery period of
10 days before individual housing and the start of ECG recording. 10 second ECG
waveform sweeps were collected every 5 min except for during autonomic blockade
were ECG was recorded continuously. Following 5 days of ECG recording mice
were given rapamycin in drinking water for 2 weeks before 5 more days of
recording. At ZT0 or ZT12, mice were given 10 mg/kg metoprolol i.p. followed by
4 mg/kg atropine to achieve total autonomic blockade, confirmed by a sharp and
prolonged decrease in heart rate variability (RR interval standard deviation).
Intrinsic heart rate was measured over 30 min following atropine injection.
ECG analysis was carried out as previously described85 using bespoke ECG
software written in MATLAB (R2018a; Mathworks, USA). Briefly, for every 10 s
sweep R waves were detected by amplitude thresholding and ECG waveforms
compared to the median of the sweep. Any that deviated significantly from this
template were removed from subsequent analysis. Any sweeps with low signal/noise
ratio or where >20% of detected events were excluded during template matching were
excluded. Heart rate was calculated from the median RR interval of each sweep.
Mice for Langendorff and telemetry studies. Male, C57BL/6 J mice aged
10–13 weeks at the start of study, purchased from Charles River (UK), were used
for ECG and Langendorff studies. Langendorff studies included some Bmal1f/f
animals bred in-house on the same C57BL/6 J background. Mice were housed
under 12:12 LD (~400/0 lux) at 22 ± 2 °C with food and water available ad libitum.
Behavioral experiment for NKCC1 KO mice. Sperm from NKCC1−/− mice
(FVB.Cg-Slc12a2tm1Ges/Mmjax, the Jackson Laboratories) was used for in vitro
fertilization of PER2::LUC transgenic mice. After two rounds of breeding within
the background strain, NKCC1+/+-PER2::LUC and NKCC1−/−PER2::LUC mice
(n= 4 males per genotype, 8–12 weeks of age) were individually housed, and
locomotor activity monitored via wheel-running. Mice were subjected to 12 h/12 h-
light/dark cycles (L/D) for 6 days then released into constant darkness (D/D) for
14 days. Period of locomotor activity was determined using ClockLab software
(Actimetrics) (last 6 days in D/D).
Osmometry. Stock solutions of 600 mg/ml hemoglobin (MP Biomedicals,
02151234), 400 mg/mL PEG-20K (Sigma, 81300), or 400 mg/mL KCl were pre-
pared in PBS. Osmolality was measured using OSMOMAT 30 (Gonotec). Three
measurements for each dilution were performed. Data were analysed using
GraphPad and fitted with either a straight line or a third order polynomial. All cell
media were adjusted to be isoosmotic within each experiment, unless otherwise
stated.
Ratiometric pH measurements. Native Fluc spectra were collected in solution using a
Cary Eclipse Fluorescence Spectrophotometer (Agilent) with 10 nM Quantilum
(Promega, Madison, WI; E1701) in 30 mM MOPS, 10mM β-mercaptoethanol,
1 mM ATP pH 7.4, 1 mM potassium luciferin, 10mMMgSO4, and 1 mg/mL bovine
serum albumin, as described previously101. Cellular pH calibration was performed
with stably transfected SV40:Luc U2OS cells at 37 °C in white 96 well plates
(Corning™ 3917) on a Tecan Spark 10M, alternately using 550–575 nm and
610–635 nm filters to calculate 560/620 nm ratio (Supplementary Fig. 2c, d) with 5 s
integration times. At the depicted timepoint, 10 μL of 10 μM FCCP was auto-
matically injected to give a final concentration of 1 μM FCCP. Longitudinal mea-
surements were also performed on a Tecan Spark 10M (Supplementary Fig. 2c, d),
under the same conditions, measuring total bioluminescence from each well (1 s
integration) in addition to emission at 550–575 and 610–635 nm from the same well
(5 s integration). For these experiments cell media was buffered with 20mM MOPS
instead of bicarbonate, as described previously88. The pH of the various media was
measured and adjusted at 37 °C with 1M HCl or NaOH, and then adjusted to
342mOsm with 1M NaCl.
Drugs. DIOA (Sigma, D129) was used at 50 μM, bumetanide (Sigma, B3023) at
100 μM, torin1 (Merck, 47599) at 50 nM, FCCP at 0.3 μM, and closantel (Sigma,
34093) at 30 μM. Rapamycin (J62473, Alfa Aesar, UK) was dissolved at 50 mg/ml
in ethanol, then diluted 1:1000 in water. Rapamycin solutions were kept shielded
from light using tin foil and changed weekly.
Statistical analysis. Statistical analyses were performed using GraphPad Prism. Data
are presented as mean ± SEM unless ostherwise stated. Statistical significance was
determined using two-tailed student’s t test or ANOVA, as appropriate. Post hoc
tests were used to correct for multiple comparisons as indicated in figure legend.
p-values are reported using the following symbolic representation: ns p > 0.05,
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
All animal experiments were licensed under 1986 Home Office Animal
Procedures Act (UK) and carried out in accordance with local animal welfare
committee guidelines.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available in the main article and
supplementary files or from the corresponding author upon reasonable request. Source
data are provided with this paper as Source Data File. The original mass spectra and
search engine files used in this study have been deposited in the public proteomics
repository MassIVE as MSV000087673 [https://massive.ucsd.edu/ProteoSAFe/
dataset.jsp?accession=MSV000087673]. Source data are provided with this paper.
Code availability
The codes used detection, tracking, and analysis of quantum dots are available for
download through GitHub (https://github.com/deriverylab/Stangherlin2021).
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